Abstract
Evidence suggests that allergic immune responses can protect against some types of cancer. What are the possible underlying mechanisms, and can allergic reactions be harnessed for anticancer therapy?
This is a preview of subscription content, log in via an institution to check access.
References
Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nature Rev. Cancer 12, 252–264 (2012).
Hwang, C. Y. et al. Cancer risk in patients with allergic rhinitis, asthma and atopic dermatitis: a nationwide cohort study in Taiwan. Int. J. Cancer 130, 1160–1167 (2012).
Palm, N. W., Rosenstein, R. K. & Medzhitov, R. Allergic host defences. Nature 484, 465–472 (2012).
Palmer, C. N. et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Genet. 38, 441–446 (2006).
Cipolat, S., Hoste, E., Natsuga, K., Quist, S. R. & Watt, F. M. Epidermal barrier defects link atopic dermatitis with altered skin cancer susceptibility. Elife 3, e01888 (2014).
Strid, J., Sobolev, O., Zafirova, B., Polic, B. & Hayday, A. The intraepithelial T cell response to NKG2D-ligands links lymphoid stress surveillance to atopy. Science 334, 1293–1297 (2011).
Ziegler, S. F. & Artis, D. Sensing the outside world: TSLP regulates barrier immunity. Nature Immunol. 11, 289–293 (2010).
Guinea-Viniegra, J. et al. Differentiation-induced skin cancer suppression by FOS, 53, and TACE/ADAM17. J. Clin. Invest. 122, 2898–2910 (2012).
Demehri, S. et al. Elevated epidermal thymic stromal lymphopoietin levels establish an antitumor environment in the skin. Cancer Cell 22, 494–505 (2012).
Di Piazza, M., Nowell, C. S., Koch, U., Durham, A. D. & Radtke, F. Loss of cutaneous TSLP-dependent immune responses skews the balance of inflammation from tumor protective to tumor promoting. Cancer Cell 22, 479–493 (2012).
Wilson, S. R. et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 155, 285–295 (2013).
Girardi, M. et al. The distinct contributions of murine T cell receptor (TCR)γδ+ and TCRαβ+ T cells to different stages of chemically induced skin cancer. J. Exp. Med. 198, 747–755 (2003).
Strid, J. et al. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nature Immunol. 9, 146–154 (2008).
Jensen-Jarolim, E. et al. AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy 63, 1255–1266 (2008).
Karagiannis, S. N. et al. Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application. Cancer Immunol. Immunother. 61, 1547–1564 (2012).
Hoste, E. et al. Innate sensing of microbial products promotes wound-induced skin cancer. Nature Commun. 6, 5932 (2015).
Acknowledgements
The authors gratefully acknowledge financial support from the UK Medical Research Council and the Wellcome Trust.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Hoste, E., Cipolat, S. & Watt, F. Understanding allergy and cancer risk: what are the barriers?. Nat Rev Cancer 15, 131–132 (2015). https://doi.org/10.1038/nrc3909
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrc3909
- Springer Nature Limited
This article is cited by
-
Clinical and immunological allergy assessment in cancer patients
Scientific Reports (2021)
-
Increased Bacterial Load and Expression of Antimicrobial Peptides in Skin of Barrier-Deficient Mice with Reduced Cancer Susceptibility
Journal of Investigative Dermatology (2016)